Krill's Disease: A Newer Management Option

Sarang P Lambat; Vinay B Nangia; Prabhat V Nangia; Neha H Shah; Swati D Mishra

doi:10.18502/jovr.v18i3.13782

Krill's Disease: A Newer Management Option

J Ophthalmic Vis Res. 2023 Jul 28;18(3):334-338. doi: 10.18502/jovr.v18i3.13782. eCollection 2023 Jul-Sep.

Authors

Sarang P Lambat¹, Vinay B Nangia¹, Prabhat V Nangia², Neha H Shah¹, Swati D Mishra¹

Affiliations

¹ Vitreoretinal Services, Suraj Eye Institute, Nagpur, India.
² Cornea and Refractive Services, Suraj Eye Institute, Nagpur, India.

Abstract

Purpose: To report a case of a young female who presented with scotoma in the right eye for few days.

Case report: Krill's disease or acute retinal pigment epithelitis (ARPE) is a self-limiting retinal disease with no specific treatment. Typical clinical and imaging features helped us to diagnose her with ARPE. Intravenous methylprednisolone (IVMP), which gives a rapid anti-inflammatory response, was advised. An SD-OCT scan post-injection showed a reduction in hyperreflectivity and height of lesion at day 3 and near total resolution by day 5.

Conclusion: This case suggests rapid resolution of ARPE with the use of IVMP.

Keywords: Intravenous Methylprednisolone; Krill's Disease; Acute Retinal Pigment Epithelitis.

Publication types

Case Reports